Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of remimazolam vs propofol on visual evoked potentials under general anesthesia
jRCT1011230057Not yet recruiting
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of remimazolam in brain neoplasm (2 arms). Primary endpoint: Amplitude of visual evoked potential N1-P1 at Oz. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
brain neoplasm
Beyond the preview
Go deeper on jRCT1011230057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1011230057.